STOCKHOLDERS’ EQUITY (Details) $ in Thousands			1 Months Ended			12 Months Ended
	Nov. 29, 2023 $ / shares shares	Aug. 24, 2023 $ / shares shares	Aug. 31, 2024 $ / shares year shares	Nov. 30, 2023 USD ($) $ / shares shares	Apr. 30, 2023 USD ($) $ / shares year shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 $ / shares shares	Aug. 24, 2024 $ / shares	Aug. 23, 2024 $ / shares	Jun. 30, 2024 USD ($)
Stockholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized (in shares)						10,000,000	10,000,000
Preferred stock, par value (in dollars per share) | $ / shares						$ 0.001	$ 0.001
Preferred stock, shares outstanding (in shares)						0	0
Common stock, shares authorized (in shares)						100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares						$ 0.001	$ 0.001
Common stock sold (in shares)				45,031	7,142
Common stock sold, price per share (in dollars per share) | $ / shares				$ 13.00	$ 210.00
Number of warrants (in shares)						1,307,842
Exercise price per share (in dollars per share) | $ / shares						$ 12.63			$ 4.35
Shelf registration, future offering availability, amount | $						$ 1,500				$ 1,600
Common stock available for issuance (in shares)						300,138
Net proceeds received for issuance of common stock | $						$ 38
Warrants issued (in shares)						1,036,279	1,195,466
Common Stock
Stockholders’ Deficit (Details) [Line Items]
Net proceeds received for issuance of common stock (in shares)						15,051
Net proceeds received for issuance of common stock | $						$ 44
Stock issued, warrants exercised (in shares)			505,502			505,962	454,444
Series C Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares					$ 194.40	$ 194.40
Gross proceeds, warrants exercised | $					$ 1,500
Placement agent fees and offering expenses | $					$ 290
Warrants issued (in shares)						0	7,142
Series C Warrants | Measurement Input, Share Price
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares					165.60
Series C Warrants | Measurement Input, Price Volatility
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input					1.64
Series C Warrants | Measurement Input, Expected Term
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | year					5.5
Series C Warrants | Measurement Input, Expected Dividend Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input					0
Series C Warrants | Measurement Input, Risk Free Interest Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input					0.034
Series C Warrants | H.C. Wainwright & Co., LLC
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares					$ 262.50
Series C Warrants | Maximum
Stockholders’ Deficit (Details) [Line Items]
Number of warrants (in shares)					7,142
Series C Warrants | Maximum | H.C. Wainwright & Co., LLC
Stockholders’ Deficit (Details) [Line Items]
Number of warrants (in shares)					534
Pre-Funded Warrants Issued In November 2023, Series D Warrants, And Series E Warrants
Stockholders’ Deficit (Details) [Line Items]
Gross proceeds, warrants exercised | $				$ 5,000
Placement agent fees and offering expenses | $				$ 800
Pre-Funded Warrants Issued In November 2023, Series D Warrants, And Series E Warrants | H.C. Wainwright & Co., LLC
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares				$ 16.25
Pre-Funded Warrants Issued In November 2023, Series D Warrants, And Series E Warrants | Maximum | H.C. Wainwright & Co., LLC
Stockholders’ Deficit (Details) [Line Items]
Number of warrants (in shares)				28,844
Pre-Funded Warrants Issued in November 2023
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares				$ 13.00		$ 13.00
Warrants issued (in shares)						0	339,585
Pre-Funded Warrants Issued in November 2023 | Measurement Input, Share Price
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares				9.30
Pre-Funded Warrants Issued in November 2023 | Measurement Input, Price Volatility
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input				2.62
Pre-Funded Warrants Issued in November 2023 | Measurement Input, Expected Dividend Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input				0
Pre-Funded Warrants Issued in November 2023 | Measurement Input, Risk Free Interest Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input				0.055
Pre-Funded Warrants Issued in November 2023 | Maximum
Stockholders’ Deficit (Details) [Line Items]
Number of warrants (in shares)				339,585
Series D Warrants and Series E Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares				$ 13.00
Series D Warrants and Series E Warrants | Maximum
Stockholders’ Deficit (Details) [Line Items]
Number of warrants (in shares)				769,228
August 2023 Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares		$ 86.40
Warrants issued (in shares)		48,911
Weighted average remaining life		2 years 1 month 6 days
August 2023 Original Warrants | Measurement Input, Share Price
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares			4.10
August 2023 Original Warrants | Measurement Input, Price Volatility
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares			1.51
August 2023 Original Warrants | Measurement Input, Expected Term
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | year			2.1
August 2023 Original Warrants | Measurement Input, Expected Dividend Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input			0
August 2023 Original Warrants | Measurement Input, Risk Free Interest Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input			0.039
November 2023 Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares	$ 13.00
Warrants issued (in shares)	456,591
Weighted average remaining life	2 years 6 months
November 2023 Original Warrants | Measurement Input, Share Price
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares								4.10
November 2023 Original Warrants | Measurement Input, Price Volatility
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | $ / shares			1.40
November 2023 Original Warrants | Measurement Input, Expected Term
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input | year			2.5
November 2023 Original Warrants | Measurement Input, Expected Dividend Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input			0
November 2023 Original Warrants | Measurement Input, Risk Free Interest Rate
Stockholders’ Deficit (Details) [Line Items]
Warrants, fair value, measurement input			0.038
Original Warrants
Stockholders’ Deficit (Details) [Line Items]
Exercise price per share (in dollars per share) | $ / shares						$ 4.60
Warrant exercise, gross proceeds | $						$ 2,300
Warrant exercise, issuance cost | $						340
Modification of terms related to certain warrants | $						$ 386
Series F-1, Series F-2 And Dealer Manager Warrants
Stockholders’ Deficit (Details) [Line Items]
Warrants issued (in shares)						1,036,279